BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deb PK, Deka S, Borah P, Abed SN, Klotz KN. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives. Curr Pharm Des 2019;25:2697-715. [PMID: 31333094 DOI: 10.2174/1381612825666190716100509] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Ju X, Wang S, Yan P, Zhu C, Hu X, Dong J, Tan Z. Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor. Front Psychiatry 2021;12:599399. [PMID: 34335318 DOI: 10.3389/fpsyt.2021.599399] [Reference Citation Analysis]
2 Deb PK. Therapeutic Potentials of Adenosine Receptors: The State of The Art. Curr Pharm Des 2019;25:2789-91. [PMID: 31674891 DOI: 10.2174/138161282526191007143942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Shaw S, Uniyal A, Gadepalli A, Tiwari V, Belinskaia DA, Shestakova NN, Venugopala KN, Deb PK, Tiwari V. Adenosine receptor signalling: Probing the potential pathways for the ministration of neuropathic pain. European Journal of Pharmacology 2020;889:173619. [DOI: 10.1016/j.ejphar.2020.173619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Francucci B, Dal Ben D, Lambertucci C, Spinaci A, Volpini R, Marucci G, Buccioni M. A patent review of adenosine A2B receptor antagonists (2016-present). Expert Opin Ther Pat 2022;:1-24. [PMID: 35387537 DOI: 10.1080/13543776.2022.2057222] [Reference Citation Analysis]
5 Val C, Rodríguez-garcía C, Prieto-díaz R, Crespo A, Azuaje J, Carbajales C, Majellaro M, Díaz-holguín A, Brea JM, Loza MI, Gioé-gallo C, Contino M, Stefanachi A, García-mera X, Estévez JC, Gutiérrez-de-terán H, Sotelo E. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A 1 Antagonists. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c01636] [Reference Citation Analysis]
6 Yang NJ, Liu YR, Tang ZS, Duan JA, Yan YF, Song ZX, Wang MG, Zhang YR, Chang BJ, Zhao ML, Zhao YT. Poria cum Radix Pini Rescues Barium Chloride-Induced Arrhythmia by Regulating the cGMP-PKG Signalling Pathway Involving ADORA1 in Zebrafish. Front Pharmacol 2021;12:688746. [PMID: 34393777 DOI: 10.3389/fphar.2021.688746] [Reference Citation Analysis]
7 Trapero C, Martín-Satué M. Purinergic Signaling in Endometriosis-Associated Pain. Int J Mol Sci 2020;21:E8512. [PMID: 33198179 DOI: 10.3390/ijms21228512] [Reference Citation Analysis]
8 Wall MJ, Hill E, Huckstepp R, Barkan K, Deganutti G, Leuenberger M, Preti B, Winfield I, Carvalho S, Suchankova A, Wei H, Safitri D, Huang X, Imlach W, La Mache C, Dean E, Hume C, Hayward S, Oliver J, Zhao FY, Spanswick D, Reynolds CA, Lochner M, Ladds G, Frenguelli BG. Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression. Nat Commun 2022;13:4150. [PMID: 35851064 DOI: 10.1038/s41467-022-31652-2] [Reference Citation Analysis]
9 Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare Mannelli L, Pugliese AM, Salvemini D. Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype. Int J Mol Sci 2021;22:7952. [PMID: 34360719 DOI: 10.3390/ijms22157952] [Reference Citation Analysis]
10 Comeo E, Trinh P, Nguyen AT, Nowell CJ, Kindon ND, Soave M, Stoddart LA, White JM, Hill SJ, Kellam B, Halls ML, May LT, Scammells PJ. Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells. J Med Chem 2021;64:6670-95. [PMID: 33724031 DOI: 10.1021/acs.jmedchem.0c02067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ya. Berzina M, Eletskaya BZ, Kayushin AL, Dorofeeva EV, Lutonina OI, Fateev IV, Paramonov AS, Kostromina MA, Zayats EA, Abramchik YA, Maltsev DV, Naumenko LV, Taran AS, Yakovlev DS, Spasov AA, Miroshnikov AI, Esipov RS, Konstantinova ID. Synthesis of 2-chloropurine ribosides with chiral amino acid amides at C6 and their evaluation as A1 adenosine receptor agonists. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105878] [Reference Citation Analysis]
12 Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V. Adenosine receptor antagonists: Recent advances and therapeutic perspective. Eur J Med Chem 2021;227:113907. [PMID: 34695776 DOI: 10.1016/j.ejmech.2021.113907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
13 Szabo AM, Viczjan G, Erdei T, Simon I, Kiss R, Szentmiklosi AJ, Juhasz B, Papp C, Zsuga J, Pinter A, Szilvassy Z, Gesztelyi R. Accuracy and Precision of the Receptorial Responsiveness Method (RRM) in the Quantification of A1 Adenosine Receptor Agonists. Int J Mol Sci 2019;20:E6264. [PMID: 31842299 DOI: 10.3390/ijms20246264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Kosmowska B, Wardas J. The Pathophysiology and Treatment of Essential Tremor: The Role of Adenosine and Dopamine Receptors in Animal Models. Biomolecules 2021;11:1813. [PMID: 34944457 DOI: 10.3390/biom11121813] [Reference Citation Analysis]
15 Giuliani AL, Sarti AC, Di Virgilio F. Ectonucleotidases in Acute and Chronic Inflammation. Front Pharmacol 2020;11:619458. [PMID: 33613285 DOI: 10.3389/fphar.2020.619458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 [DOI: 10.1101/2020.04.04.023945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Barresi E, Martini C, Da Settimo F, Greco G, Taliani S, Giacomelli C, Trincavelli ML. Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications. Front Pharmacol 2021;12:652121. [PMID: 33841166 DOI: 10.3389/fphar.2021.652121] [Reference Citation Analysis]
18 Dal Ben D, Lambertucci C, Buccioni M, Martí Navia A, Marucci G, Spinaci A, Volpini R. Non-Nucleoside Agonists of the Adenosine Receptors: An Overview. Pharmaceuticals (Basel) 2019;12:E150. [PMID: 31597388 DOI: 10.3390/ph12040150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
19 Hallaj S, Mirza-Aghazadeh-Attari M, Arasteh A, Ghorbani A, Lee D, Jadidi-Niaragh F. Adenosine: The common target between cancer immunotherapy and glaucoma in the eye. Life Sci 2021;282:119796. [PMID: 34245774 DOI: 10.1016/j.lfs.2021.119796] [Reference Citation Analysis]
20 Borah P, Hazarika S, Deka S, Venugopala KN, Nair AB, Attimarad M, Sreeharsha N, Mailavaram RP. Application of Advanced Technologies in Natural Product Research: A Review with Special Emphasis on ADMET Profiling. Curr Drug Metab 2020;21:751-67. [PMID: 32664837 DOI: 10.2174/1389200221666200714144911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Coppi E, Dettori I, Cherchi F, Bulli I, Venturini M, Lana D, Giovannini MG, Pedata F, Pugliese AM. A2B Adenosine Receptors: When Outsiders May Become an Attractive Target to Treat Brain Ischemia or Demyelination. Int J Mol Sci 2020;21:E9697. [PMID: 33353217 DOI: 10.3390/ijms21249697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Silkis IG. Role of Acetylcholine and GABAergic Inhibitory Transmission in Seizure Pattern Generation in Neural Networks Integrating the Neocortex, Hippocampus, Basal Ganglia, and Thalamus. Neurochem J 2020;14:150-66. [DOI: 10.1134/s1819712420020129] [Reference Citation Analysis]
23 Deb PK. Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptors. CPD 2019;25:2695-6. [DOI: 10.2174/138161282525190916100149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
24 Coppi E, Cherchi F, Venturini M, Lucarini E, Corradetti R, Di Cesare Mannelli L, Ghelardini C, Pedata F, Pugliese AM. Therapeutic Potential of Highly Selective A3 Adenosine Receptor Ligands in the Central and Peripheral Nervous System. Molecules 2022;27:1890. [PMID: 35335254 DOI: 10.3390/molecules27061890] [Reference Citation Analysis]